Antibiotic stewardship in Germany: A cross-sectional questionnaire survey of 355 intensive care units

Infection

Volumn 42, Issue 1, 2014, Pages 119-125

  Maechler, F ^a   Schwab, F ^a   Geffers, C ^a   Meyer, E ^a   Leistner, R ^a   Gastmeier, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antibiotic stewardship; Antibiotics; Cross sectional studies; Management; Prescription

Indexed keywords

ANTIBIOTIC AGENT; COLISTIN; DAPTOMYCIN; LINEZOLID;

ACCESS TO INFORMATION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC STEWARDSHIP; ANTIBIOTIC THERAPY; ARTICLE; CROSS-SECTIONAL STUDY; DRUG COST; DRUG USE; GERMANY; HEALTH CARE SURVEY; HOSPITAL INFECTION; HOSPITAL PHARMACY; HOSPITAL POLICY; HUMAN; INFECTION CONTROL PRACTITIONER; INTENSIVE CARE UNIT; MICROBIOLOGY; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIVATE HOSPITAL; PUBLIC HOSPITAL; QUESTIONNAIRE; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; GERMANY; HUMANS; INTENSIVE CARE UNITS; QUESTIONNAIRES;

EID: 84898463537     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0531-y     Document Type: Article

References (35)

1. Davey P,Brown E, Charani E, Fenelon L,Gould IM,HolmesA, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543.
2. Paskovaty A, Pflomm JM, Myke N, Seo SK. A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century. Int J Antimicrob Agents. 2005;25:1-10. (Pubitemid 40023340)
3. Wagenlehner FM, Hoyme U, Kaase M, Fünfstück R, Naber KG, Schmiemann G. Uncomplicated urinary tract infections. Dtsch Arztebl Int. 2011;108:415-23.
4. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27-72. (Pubitemid 46290553)
5. Hohmann C, Eickhoff C, Radziwill R, Schulz M. Adherence to guidelines for antibiotic prophylaxis in surgery patients in German hospitals: a multicentre evaluation involving pharmacy interns. Infection. 2012;40:131-7.
6. van der Velden LB, Tromp M, Bleeker-Rovers CP, Hulscher M, Kullberg BJ, Mouton JW, et al. Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy. Eur J Clin Microbiol Infect Dis. 2012;31:1561-8.
7. George P, Morris AM. Pro/con debate: Should antimicrobial stewardship programs be adopted universally in the intensive care unit? Crit Care. 2010;14:205.
8. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18:638-56. (Pubitemid 41504509)
9. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77. (Pubitemid 46084814)
10. Pope SD, Dellit TH, Owens RC, Hooton TM. Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol. 2009;30:97-8.
11. Prins JM, Degener JE, de Neeling AJ, Gyssens IC. Experiences with the Dutch Working Party on antibiotic policy (SWAB). Euro Surveill. 2008;13. pii: 19037.
12. Kern WV, Steib-Bauert M, Amann S, Fellhauer M, de With K. Hospital antibiotic management in Germany - results of the ABS maturity survey of the ABS International group. Wien Klin Wochenschr. 2008;120:294-8. (Pubitemid 351845338)
13. Gastmeier P, Sohr D, Schwab F, Behnke M, Zuschneid I, Brandt C, et al. Ten years of KISS: the most important requirements for success. J Hosp Infect. 2008;70:11-6.
14. Meyer E, Sohr D, Gastmeier P, Geffers C. New identification of outliers and ventilator-associated pneumonia rates from 2005 to 2007 within the German Nosocomial Infection Surveillance System. J Hosp Infect. 2009;73:246-52.
15. WHO global strategy for containment of antimicrobial resistance. 2001. http://whqlibdoc.who.int/hq/2001/WHO-CDS-CSR-DRS-2001.2.pdf. Accessed 2 Aug 2013.
16. ECDC. Antimicrobial resistancesurveillance in Europe 2011. 2012. http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance- surveillance-europe-2011.pdf. Accessed 2 Aug 2013.
17. Critchley IA, Karlowsky JA. Optimal use of antibiotic resistance surveillance systems. Clin Microbiol Infect. 2004;10:502-11. (Pubitemid 38961574)
18. Larson EL, Quiros D, Giblin T, Lin S. Relationship of antimicrobial control policies and hospital and infection control characteristics to antimicrobial resistance rates. Am J Crit Care. 2007;16:110-20.
19. Meyer E, Gastmeier P. Surveillance of antibiotic use and resistance. Anasthesiol Intensivmed Notfallmed Schmerzther. 2007;42:116-20.
20. Carbonne A, Arnaud I, Maugat S, Marty N, Dumartin C, Bertrand X, et al. National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. J Antimicrob Chemother. 2013;68:954-9.
21. Fridkin SK, Lawton R, Edwards JR, Tenover FC, McGowan JE Jr, Gaynes RP. Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci. Emerg Infect Dis. 2002;8:702-7. (Pubitemid 34764736)
22. Chaberny IF, Wriggers A, Behnke M, Gastmeier P. Antibiotics: MRSA prevention measures in German hospitals: results of a survey among hospitals, performed as part of the MRSA-KISS module. Dtsch Arztebl Int. 2010;107:631-7.
23. Kuster SP, Ruef C, Ledergerber B, Hintermann A, Deplazes C, Neuber L, et al. Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting. Infection. 2008;36:549-59.
24. KRINKO. Surveillance nosokomialer Infektionen sowie die Erfassung von Erregern mit speziellen Resistenzen und Multiresistenzen § 6 Abs. 3 und § 23 Abs. 1 und 2 in Verbindung mit § 4 Abs.2 Nr. 2b IfSG. Rechtliche Voraussetzungen und Umsetzungsempfehlungen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2000;43:887-90.
25. KRINKO. Surveillance nosokomialer Infektionen sowie die Erfassung von Krankheits-erregern mit speziellen Resistenzen und Multiresistenzen. Fortschreibung der Liste der gemäß §4 Abs. 2 Nr.2 Buchstabe b in Verbindung mit §23 Abs.4 IfSG zu erfassenden nosokomialen Infektionen und Krankheitserreger mit speziellen Resistenzen und Multiresistenzen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:580-3.
26. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;6:CD000259.
27. Woodward RS, Medoff G, Smith MD, Gray JL 3rd. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school- affiliated hospital. Am J Med. 1987;83:817-23. (Pubitemid 18098153)
28. Frank MO, Batteiger BE, Sorensen SJ, Hartstein AI, Carr JA, McComb JS, et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care. 1997;5:180-8.
29. John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:471-85. (Pubitemid 27096806)
30. McGowan JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol. 1994;15:478-83.
31. Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother. 1999;43:459-65. (Pubitemid 29182293)
32. Cooke FJ, Choubina P, Holmes AH. Postgraduate training in infectious diseases: investigating the current status in the international community. Lancet Infect Dis. 2005;5:440-9. (Pubitemid 40840734)
33. Schweickert B, Kern WV, de With K, Meyer E, Berner R, Kresken M, et al. Surveillance of antibiotic consumption: Clarification of the ''definition of data on the nature and extent of antibiotic consumption in hospitals according to section sign 23 paragraph 4 sentence 2 of the IfSG''. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:903-12.
34. Bruce J, MacKenzie FM, Cookson B, Mollison J, van der Meer JW, Krcmery V, et al. Antibiotic stewardship and consumption: findings from a pan-European hospital study. J Antimicrob Chemother. 2009;64:853-60.
35. Zoutman DE, Ford BD. The relationship between hospital infection surveillance and control activities and antibiotic-resistant pathogen rates. Am J Infect Control. 2005;33:1-5. (Pubitemid 40430788)